Products catalog of Generic APIs
Each site in Seqens’ global manufacturing network is committed to development and manufacturing excellence
France
- Aramon: cGMP production of clinical stage APIs and intermediates from grams to multi-ton commercial scale
- Bourgoin: Pre-GMP production of regulatory starting material from kilograms to multi-ton commercial scale
- Couterne: Pre-GMP production of regulatory starting material from kilograms to multi-ton commercial scale
- Limay: cGMP production of large volume APIs and intermediaries from grams to multi-ton commercial scale
- Nimes: Biocatalysis and custom enzymes (Proteus)
- Porcheville: R&D and pilot units for contract small molecule API development
- Villeneuve-la-Garenne: cGMP production of potent molecules from grams to multi-ton commercial scale
Finland
- Turku: cGMP production of proprietary APIs from grams to multi-ton commercial scale
Germany
- Lahr: cGMP production of APIs and pharmachemicals from grams to multi-ton commercial scale and pre-GMP production of regulatory starting material from kilograms to multi-ton commercial scale
United States
- Devens: R&D and pilot units for contract small molecule API development; production of controlled substances (Schedule II-V)
- Newburyport: cGMP production of APIs and pharmachemicals from grams to multi-ton commercial scale
Our locations
Couterne
France
Address
Route de Lassay
61410Couterne
61410Couterne
Business Line
Lubbricant Additives, Fine Chemicals
Phone
+33 2 33 37 50 20
Market
Specialty Ingredients
Mail
info.AS@seqens.com
More information
Surface: 120, 000 m²
Capabilities: 190 m³ of ISO 9001 reactors and kilo-lab
Flagship technologies: Most standard organic synthesis reactions (large volumes)
Certifications: ISO 9001
Lahr
Germany
Address
Raiffeisenstraße 4
77933 Lahr
77933 Lahr
Business Line
Custom Manufacturing, APIs & Intermediates
Phone
49 7821 585 0
Market
Pharmaceutical
Mail
info-lahr@seqens.com
More information
Surface: 48 000 m²
Lab surface: 700 m²
Capabilities:
- Total reactor capacity: 92 m³
- Reaction vessels: 1 to 6 300 L; temperature -80°C to +250 °C
- Multi-purpose state of the art cGMP facilty: 4 independent, vertical integrated production trains 800 L train, 2 x 3 000 L trains plus 1 x 3 000 L low temperature hydrogenation reactor and 6 000 L train
- Classic two-floor layout Facility: 20 vessels with capacity between 800 and 6 000 L (glaslined and SS)
- Autoclaves (operational range up to 100 bar)
- Kilo-Lab: 3 reactors: 25 / 100 / 250 L
Flagship technologies:
- Hydrogenation
- Reductive amination
- Organometallic reactions
- Protected AADs (Aminoacid derivatives)
- Carbonylation & Hydroformylation
- Pressure aminolysis, other reactions under pressure
- Cryogenic chemistry
- Enantiopure synthesis
- Cyanation high volumes (NaCN) C-C coupling
- Reductions
- Halogenation
Last inspections:
- FDA 2018
- German Pharma Authority 2018
Certifications:
- GMP
- ISO 9001
- ISO 50001
Number of scientists: 25
Limay
France
Address
19 Route de Meulan
78520 Limay
78520 Limay
Business Line
Contract Manufacturing & Proprietary APIs
Phone
+33 1 34 78 87 87
Market
Pharmaceutical
Mail
info.cdmo@seqens.com
More information
Capabilities:
- 70 m³ of GMP reactors
- 100 L – 8 000 L vessels
Flagship technologies:
- Optical resolution
- Enzymatic hydrolysis
- Enantioselective reduction
- Low-temperature reactions (-80 °C)
- Specific reduction
- Hydrogenation (40 bar)
- Organomagnesium compounds
- Thin-layer distillation
EcoVadis CSR Rating: Gold Certification 2019
Last inspections :
- FDA 2018
- ANSM 2019
Aramon
France
Address
Expansia, Route d'Avignon
30390 Aramon
30390 Aramon
Business Line
Contract Manufacturing
Phone
+33 4 66 57 01 01
Market
Pharmaceutical
Mail
info.cdmo@seqens.com
More information
Capabilities:
- 100 m³ of GMP reactors
- 50 L – 10 000 L vessels
Flagship technologies:
- Organometallic chemistry
- Large-scale hydrogenation
- Diborane chemistry
- Ethylene oxide reactions
- Biocatalysis platform
- Polymer production (PLGA)
- Enzymatic synthesis Skraup reactions
Last inspections:
- FDA 2018
- ANSM 2021
EcoVadis CSR Rating: Silver certification
Bourgoin-Jallieu
France
Address
15 Avenue des Frères Lumière
38300 Bourgoin-Jallieu
38300 Bourgoin-Jallieu
Business Line
Contract Manufacturing & Fine Chemicals
Phone
+33 4 74 93 63 33
Market
Pharmaceutical
Mail
Accueil.bourgoin@seqens.com
More information
Flagship technologies: Distillation
Villeneuve la Garenne
France
Address
35 Avenue Jean Jaurès
92390 Villeneuve-la-Garenne
92390 Villeneuve-la-Garenne
Business Line
Contract Manufacturing & Proprietary APIs
Phone
+33 1 34 78 87 87
Market
Pharmaceutical
Mail
info.cdmo@seqens.com
More information
Capabilities:
- 70 m³ of GMP reactors
- 100 L – 8 000 L vessels
Flagship technologies:
- Optical resolution
- Enzymatic hydrolysis
- Enantioselective reduction
- Low-temperature reactions (-80 °C)
- Specific reduction
- Hydrogenation (40 bar)
- Organomagnesium compounds
- Thin-layer distillation
Last inspections:
- ANSM 2019
- ANVISA (Brasil) 2018
- FDA 2016
Turku
Finland
Address
Messukentänkatu 8
20210 Turku
20210 Turku
Business Line
Contract Manufacturing & Proprietary APIs
Phone
+358 2 330 5542
Market
Pharmaceutical
Mail
info@pcasfinland.fi
More information
Surface: 11 678 m²
Lab surface: 695 m²
Capabilities:
- 4 separate modules
- 72 m³ reactor capacity-
- 250 L – 6300 L vessels
Flagship technologies:
- Biphosphonate chemistry
- Hydrogenation (20 bar)
- Chlorination
- Cyanation (NaCN) in separate installations
- Reduction with complex hydrids
- Biocatalysis
- Manufacturing of parenteral/injectable APIs
- Separate production modules and final processing facilities
Last inspections:
- FDA 2019
- PMDA 2018
- FIMEA 2018
Number of scientists: 16
Porcheville
France
Address
ZI de Limay 2, 8 Rue de Rouen
78440Porcheville
78440Porcheville
Phone
+33 1 34 79 57 00
Market
Pharmaceutical, Specialty Ingredients & Cosmetics
Mail
ContactSeqensPCV@seqens.com
More information
Surface: 40 000 m²
Lab surface: 2 000 m²
Capabilities:
- 4 kilo-labs
- 2 cGMP pilot plants with 11 multipurpose reactors from 100 L to 2 800 L (total capacity of 12 m³)
- Temperature range: -15/+150°C (hastelloy reactor: -80/+200°C)
- 3 finishing rooms (agitated filter dryers, filters, dryers, milling and sieving equipments)
Flagship technologies:
- Crystallization expertise and technologiesd(salt, co-crystal and polymorph screenings, process development)
- Process Safety expertise and tecnologies
- Flow chemistry for fine chemicals
- Potent API process development
- Genotoxic Impurities
- Issue Management
- Generic A.P.I Solid state expertis
Last inspection: ANSM October 2018
Certification: cGMP
Number of scientists: 110
Other: Ecosystem Pharma with integrated services
Protéus by Seqens
France
Address
70 Allée Graham Bell
30000 Nîmes
30000 Nîmes
Phone
+33 4 66 70 64 64
Market
Pharmaceutical, Specialty Ingredients & Cosmetics
Mail
seqensrdnimesinfo@seqens.com
More information
Surface: 1 000 m²
Lab surface: 500 m²
Capacities:
- 1 kilo-lab in fermentation (80 L total capacity)
- Robotic platform for highthroughput screening (HTS)
- Analytical platform for chromatography (GC, GC-MS, U-HPLC)
Flagship technologies:
- Protein engineering
- Microbiology aerobic & anaerobic
- Syngas fermentation
- Enzymes & strains fermentation
- Biochemistry
- Biocatalysis
- Design of experiments (DoE)
- Data mining
Number of scientists: 19
Devens
United States
Address
88 Jackson Road, Building 649
MA 01434Devens
MA 01434Devens
Business Line
R&D center
Phone
(978) 772 2111
Market
Pharmaceutical
Mail
Accueil@seqens.com
More information
Lab surface: 1 000 m²
Capabilities:
- Controlled substances (Schedule II-V)
- 5 Kilo-Labs
Number of scientists: 30
Newburyport
United States
Address
9 Opportunity Way
MA 01950 Newburyport
MA 01950 Newburyport
Business Line
Custom Early Phase Pharmaceutical
Phone
(978) 462 5555
Market
Pharmaceutical
Mail
Early Stage: derek.richards@seqens.com
Custom Manufacturing: don.laferle@seqens.com
Proprietary API: laurent.alexandre@seqens.com
Custom Manufacturing: don.laferle@seqens.com
Proprietary API: laurent.alexandre@seqens.com
More information
Surface: 5, 600 m²
Lab surface: 460 m²
Capabilities:
- Process Research – Custom synthesis & synthetic route evlaution from g – kg for API’s or intermediates
- Process Development – Custom synthesis from kg – metric tons
- cGMP Small Molecule API Manufacturing (Phase 1, Phase 2, Phase 3, Commerical)
- cGMP Medical Grade Polymers, Analytical Method Development
Flagship technologies:
- Controlled Substances
- Cryogenic Chemistry -90°C
- Lyophilization, Small/Large Scale Chromatography
- Tangential Flow Filtration
Last inspection: July 2018 FDA Inspection
